The inflammatory bases of hepatic encephalopathy

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 12, 2006, Pages 1297-1310

  Arias, Jorge Luis ^a   Aller, Maria Angeles ^b   Sánchez Patan, Fernando ^b   Arias, Jaime ^b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Glia; Hepatic encephalopathy; Inflammation

Indexed keywords

ANGIOGENESIS; EDEMA; ENZYME SYNTHESIS; HEPATIC ENCEPHALOPATHY; HUMAN; INFLAMMATION; ISCHEMIA; NERVOUS SYSTEM DEVELOPMENT; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TISSUE REPAIR;

ACUTE DISEASE; ASTROCYTES; CHRONIC DISEASE; ENCEPHALOMYELITIS; HEPATIC ENCEPHALOPATHY; HUMANS; OXIDATIVE STRESS; T-LYMPHOCYTE SUBSETS;

EID: 33750944610     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000243873.94572.de     Document Type: Review

References (158)

1. Hazell AS, Butterworth RF. Hepatic encephalopathy: an update of pathophysiologic mechanism. Proc Soc Exp Biol Med 1999; 222:99-112.
2. Butterworth RF. Pathogenesis of hepatic encephalopathy: update on molecular mechanisms. Indian J Gastroenterol 2003; 22 (Suppl 2):S11-S16.
3. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT; the Members of the Working Party. Hepatic encephalopathy - definition, nomenclature, diagnosis and quantification: final report of the working party at the 11th World Congress of Gastroenterology, Vienna 1998. Hepatology 2002; 35:716-721.
4. Chamuleau AFM. Animal models of hepatic encephalopathy. Semin Liver Dis 1996; 16:265-270.
5. Rozga J, Demetriou AA. Animal models of liver failure. In: Souba W, Wilmore W, editors. Surgical research. London: Academic Press; 2001. pp. 623-636.
6. Orloff MJ. Portal hypertension and porta-caval shunt. In: Souba W, Wilmore DW. Surgical research. London: Academic Press; 2001. pp. 637-701.
7. Norenberg MD. Astrocytic-ammonia interactions in hepatic encephalopathy. Semin Liver Dis 1996; 16:245-253.
8. Butterworth RF. Complications of cirrhosis. III. Hepatic encephalopathy. J Hepatol 2000; 32 (Suppl 1):171-180.
9. Victor MD, Adams RD, Cole M. The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine (Baltimore) 1965; 44:345-396.
10. Aloisi F. The role of microglia and astrocytes in CNS immune-surveillance and immunopathology. Adv Exp Med Biol 1999; 468:123-133.
11. Perea G, Araque A. Communication between astrocytes and neurons: a complex language. J Physiol (Paris) 2002; 96:199-207.
12. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005; 57:173-185.
13. Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders. HIV-associated dementia, Alzheimer disease and multiple sclerosis. J Neurol Sci 2002; 202:13-23.
14. Block ML, Hong J-S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005; 76:77-98.
15. Stewart CA, Cerhan J. Hepatic encephalopathy: a dynamic or static condition. Metab Brain Dis 2005; 20:193-204.
16. Marchetti B, Abbracchio MP. To be or not to be (inflamed): is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? Trends Pharmacol Soc 2005; 26:517-525.
17. Kato MD, Hughes RD, Keays RT, Williams R. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology 1992; 15:1060-1066.
18. Lewis M, Howdle PD. The neurology of liver failure. Q J Med 2003; 96:623-633.
19. Shawcross D, Jalan R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci 2005; 62:2295-2304.
20. Shawcross D, Davies N, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 2004; 40:247-254.
21. Vaquero J, Polson J, Chung C, Helenowski I, Schiodt FV, Reisch J, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 2003; 125:755-764.
22. Aller MA, Arias JL, Nava MP, Arias J. Posttraumatic inflammation is a complex response based on the pathological expression of the nervous, immune and endocrine functional systems. Exp Biol Med 2004; 229:170-181.
23. Aller MA, Arias JL, Arias J. Post-traumatic inflammatory response: perhaps a succession of phases with a nutritional purpose. Med Hypotheses 2004; 63:42-46.
24. Aller MA, Arias JL, Lorente L, Nava MP, Durán HJ, Arias J. Neuro-immune-endocrine functional system and vascular pathology. Med Hypotheses 2001; 57:561-569.
25. Aller MA, Arias JL, Arias J. Evolutive trophic phases of the systemic acute inflammatory response, oxygen use mechanisms and metamorphosis. Psicothema 2004; 16:369-372.
26. 2A receptors. Ann Rev Immunol 2004; 22:657-682.
27. Hori J, Ng TF, Shatos M, Klassen H, Streilein JW, Young MJ. Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells 2003; 21:405-416.
28. Medawar P. Immunity to homologous grafted skin. III: The fate of skin homografts transplanted to the brain, to subcutaneous tissue and to the anterior chamber of the eye. Br J Exp Pathol 1948; 25:58-69.
29. Lotan M, Schwartz M. Cross talk between the immune system and the nervous system in response to injury: implications for regeneration. FASEB J 1994; 8:1026-1033.
30. Lazarov-Spiegler O, Solomon AS, Zeev-Brann AB, Hirschberg DL, Lavie V, Schwartz M. Transplantation of activated macrophages overcomes central nervous system regrowth failure. FASEB J 1996; 10:1296-1302.
31. Duchini A. The role of central nervous system endothelial cell activation in the pathogenesis of hepatic encephalopathy. Med Hypotheses 1996; 46:239-244.
32. Cines DB, Pollack ES, Buck CA, Loscalzo J, Zimmerman GA, Mc Ever RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91:3527-3561.
33. Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983; 244:G52-G57.
34. Abelmann WH. Hyperdynamic circulation in cirrhosis: a historical perspective. Hepatology 1994; 20:1356-1358.
35. Song D, Liu H, Sharkey KA, Lee SS. Hyperdynamic circulation in portal-hypertensive rats is dependent on central c-fos gene expression. Hepatology 2002; 35:159-166.
36. Dincer D, Besisk F, Demirkol O, Demir K, Kaymayoglu S, Cakaloglu Y, et al. Relationships between hemodynamic alterations and Child-Pugh score in patients with cirrhosis. Hepato-Gastroenterology 2005; 52:1521-1525.
37. Lopez-Talavera JC, Merrill WW, Groszmann RJ. Tumor necrosis factor: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 1999; 108:761-767.
38. Palma MD, Aller MA, Vara E, Nava MP, García C, Arias-Díaz J, et al. Portal hypertension produces an evolutive hepato-intestinal pro- and antiinflammatory response in the rat. Cytokine 2005; 31:213-226.
39. Ahl B, Weissenborn K, Van den Of J, Fisher-Wasels K, Köstler H, et al. Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 2004; 40:73-79.
40. Lockwood AH, Yap EWH, Rhoades HM, Wong W. Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cereb Blood Flow Metab 1991; 11:331-336.
41. Norenberg MD. Oxidative and nitrosative stress in ammonia neurotoxicity. Hepatology 2003; 37:245-247.
42. Norenberg MD, Jayakumar AR, Rama Rao KV. Oxidative stress in the pathogenesis of hepatic encephalopathy. Metab Brain Dis 2004; 19:313-329.
43. Rama Rao KV, Jayakumar AR, Norenberg MD. Role of oxidative stress in the ammonia-induced mitochondrial permeability transition in cultured astrocytes. Neurochem Intern 2005; 47:31-38.
44. Häussinger D, Kircheis G, Fischer R, Schliess F, Vom Dahl S. Hepatic encephalopathy in chronic liver disease, a clinical manifestation of astrocyte swelling and low grade cerebral edema. J Hepatol 2000; 32:1035-1038.
45. Bai G, Rama Rao KV, Murthy CR, Panickar KS, Jayakumar AR, Norenberg MD. Ammonia induces the mitochondrial permeability transition in primary cultures of rat astrocytes. J Neurosci Res 2001; 66:981-991.
46. Ong JP, Aggarwal A, Krieger D, Easley KA, Karafa MT, Van Lente F, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med 2003; 114:188-193.
47. Schawcross DL, Damink SWMO, Butterworth RF, Jalan R. Ammonia and hepatic encephalopathy: the more things change, the more they remain the same. Metab Brain Dis 2005; 20:169-179.
48. Häussinger D, Schliess F. Astrocyte swelling and protein tyrosine nitration in hepatic encephalopathy. Neurochem Intern 2005; 47:64-70.
49. Pilbeam CM, Anderson RM, Bhatal PS. The brain in experimental portal-systemic encephalopathy: I. Morphological changes in three animal models. J Pathol 1983; 140:331-345.
50. Dienel GA, Cruz NF. Nutrition during brain activation: does cell-to-cell lactate shuttling contribute significantly to sweet and sour food for thought? Neurochem Intern 2004; 45:321-351.
51. Magistretti PJ, Pellerin L. Astrocytes couple synaptic activity to glucose utilization in the brain. News Physiol Sci 1999; 14:177-182.
52. Aubert A, Costalat R, Magistretti PJ, Pellerin L. Brain lactate kinetics: modeling evidence for neuronal lactate uptake upon activation. Proc Natl Acad Sci USA 2005; 45:16448-16453.
53. Pellerin L. How astrocytes feed hungry neurons. Mol Neurobiol 2005; 32:59-72.
54. Hansson E, Rönnbäck L. Astrocytes in glutamate neurotransmission. FASEB J 1995; 9:343-350.
55. Johnston M, Zakharov A, Papaiconomou C, Salmasi G, Armstrong D. Evidence of connection between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species. Cerebrospinal Fluid Res 2004; 1:2-14.
56. Koh L, Zakharov A, Johnston M. Integration of the subarachnoid space and lymphatics: is it time to embrace a new concept of cerebrospinal fluid absorption? Cerebrospinal Fluid Res 2005; 2:6-16.
57. Nathan C. Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J Clin Inves 2003; 111:769-778.
58. Nathan C. Oxygen and the inflammatory cell. Nature 2003; 422:675-676.
59. Anderson AK, Rönback L, Hansson E. Lactate induces tumor necrosis factor-α, interleukin-6 and interleukin-1 release in microglial- and astroglial-enriched primary cultures. J Neurochem 2005; 93:1327-1333.
60. Butterworth RF. Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings. Metab Brain Dis 2001; 16:55-65.
61. Blasko I, Stampfer-Kountchev M, Robatscher V, Veerhuis R, Eikelenboom P, Grubeck-Loebenstein B. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell 2004; 3:169-176.
62. Raivich G. Like cops on the beat: the active role of resting microglia. Trends Neurosci 2005; 28:571-573.
63. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996; 19:312-318.
64. Fischer-Smith T, Croul S, Adeniyi A, Rybicka K, Morgello S, Khalili K, et al. Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am J Pathol 2004; 164:2089-2099.
65. Mrak RE, Griffin WST. Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 2005; 26:349-354.
66. Lue LF, Rydel R, Brigham EF, Yang LB, Hampel H, Murphy GM Jr, et al. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 2001; 35:72-79.
67. Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: intrinsic immune effector cell of the brain. Brain Res Rev 1995; 20:269-287.
68. Felderhoff-Mueser U, Schmidt OI, Oberhozzer A, Bührer C, Stahel PF. IL-18: a key player in neuroinflammation and neurodegeneration? Trends Neurosci 2005; 28:487-493.
69. Liberto CM, Albretch PJ, Herx LM, Yong VW, Levison SW. Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem 2004; 89:1092-1100.
70. Mander P, Brown GC. Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death: a dualkey mechanism of inflammatory neurodegeneration. J Neuroinflammation 2005; 2:20-35.
71. Mattson MP. NF-kB in the survival and plasticity of neurons. Neurochem Res 2005; 30:883-893.
72. Gao HM. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem 2002; 81:1285-1297.
73. Bergeron M, Reader TA, Layrargues GP, Butterworth RF. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem Res 1989; 14:853-859.
74. Arias J, Alsasua A, Estébanez E, López ML, Arias JI, Durán M, et al. Experimental portosystemic encephalopathy: values of noradrenaline, dopamine, and homovanillic acid in the CNS of rat at 15, 30 and 60 days after terminolateral porto-caval anastomosis. Rev Esp Enf Dig 1982; 61:105-112.
75. Bergeron M, Swain MS, Reader TA, Butterworth RF. Increased mesocortical dopaminergic function following ammonia administration to rats with portacaval anastomosis. Neurochem Res 1995; 10:79-86.
76. Arias J, Alsasua A, López-Sánchez ML, Estébanez E, Durán H. Increase of serotonin in the C.N.S. of rats with portocaval shunt. Rev Esp Enf Digest 1980; 58:11-14.
77. Tossman U, Delin A, Erxsson LS, Ungerstedt U. Brain cortical amino acids measured by intracerebral dialysis in portacaval shunted rats. Neurochem Sci 1987; 12:265-269.
78. Lavoie J, Giguere JF, Layrargues GP, Butterworth RF. Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J Neurochem 1987; 49:692-697.
79. Bengtsson F, Bugge M, Johansen KH, Butterworth RF. Brain tryptophan hydroxylation in the portacaval shunted rat: a hypothesis for the regulation of serotonin turnover in vivo. J Neurochem 1991; 56:1069-1074.
80. Ekdahl CT, Claasen J-H, Bonde S, Kokaia Z, Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci 2003; 100:13632-13637.
81. Murdoch C, Muthana M, Lewis CE. Hypoxia regulates macrophage functions in inflammation. J Immunol 2005; 175:6257-6263.
82. Lazarov-Spiegler O, Solomon AS, Zeev-Brann AB, Hirschberg DL, Lavie V, Schwartz M. Transplantation of activated macrophages overcomes central nervous system regrowth failure. FASEB J 1996; 10:1296-1302.
83. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 2004; 24:2143-2155.
84. Goldman S. Glia as neural progenitor cells. Trends Neurosci 2003; 26:590-596.
85. Tzeng SF, Hsiao HY, Mak OT. Prostaglandins and cyclooxygenases in glial cells during brain inflammation. Curr Drug Targets Inflamm Allergy 2005; 4:335-340.
86. Mrak RE, Griffin WS. Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 2005; 26:349-354.
87. Becher B, Prat A, Antel JP. Brain-immune connection: immunoregulatory properties of CNS-resident cells. Glia 2000; 29:293-304.
88. Magnus T, Chan A, Graver O, Toyka KV, Gold R. Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J Immunol 2001; 167:5004-5010.
89. Shaked I, Porat Z, Gersner R, Kipnis J, Schwartz M. Early activation of microglia as antigen-presenting cells correlates with T-cell-mediated protection and repair of the injured central nervous system. J Neuroimmunol 2004; 146:84-93.
90. Schwartz M, Kipnis J. Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegeneration diseases. J Neurol Sci 2005; 233:163-166.
91. + regulatory T cells. Ann NY Acad Sci 2005; 1051:701-708.
92. Shaked I, Tchoresh D, Gersner R, Meiri G, Mordechai S, Xiao X, et al. Protective autoimmunity: interferon enables microglia to remove glutamate without evoking inflammatory mediators. J Neurochem 2005; 92:997-1009.
93. Jayakumar AR, Rama Rao KV, Noremberg MD. Glutamine-induced free radical production in cultured astrocytes. Glia 2004; 46:296-302.
94. Strauss E, de Sa Ribeiro MFG. Bacterial infections associated with hepatic encephalopathy: prevalence and outcome. Ann Hepatol 2003; 2:41-45.
95. Albillos A, de la Hera A, Gozález M, Moya JL, Calleja JL, Monserrat J, et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003; 37:208-217.
96. Albillos A, de la Hera A, Alvárez-Món M. Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet 2004; 363:1608-1610.
97. Kipnis J, Yoles E, Mizrahi T, Ben-Nur A, Schwartz M. Myelin-specific Th1 cells are necessary for post-traumatic protective autoimmunity. J Neuroimmunol 2002; 130:78-85.
98. Schwartz M, Kipnis J. Harm or heal-divergent effects of autoimmune neuroinflammation? Trends Immunol 2003; 24:7-8.
99. Streit WJ. Microglia and neuroprotection: implications for Alzheimer's disease. Brain Res Rev 2005; 48:234-239.
100. Arias JI, Aller MA, Arias J. The use of inflammation by tumor cells. Cancer 2005; 104:223-228.
101. Lingen MW. Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing. Arch Pathol Lab Med 2001; 125:67-71.
102. Monaco JL, Lawrence T. Acute wound healing. An overview. Clin Plastic Surg 2003; 30:1-12.
103. Matino G. How the brain repairs itself: new therapeutic strategies in inflammatory and degenerative CNS disorders. Lancet Neurol 2004; 3:372-378.
104. Davies SJ. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 1997; 390:680-683.
105. Jones EA, Weissenborn K. Neurology and the liver. J Neurol Neurosurg Psychiatry 1997; 63:279-293.
106. Viggiano TR, Gostout CJ. Portal hypertensive intestinal vasculopathy: a review of the clinical, endoscopic and histopathologic features. Am J Gastroenterol 1992; 87:944-954.
107. Nagral AS, Joshi AS, Bhatia SJ, Abraham P, Mistry FP, Vora IM. Congestive jejunopathy in portal hypertension. Gut 1993; 34:694-697.
108. Sherlock S. The portal venous system and portal hypertension. In: Sherlock S, editor. Diseases of the liver and biliary system. 8th ed. Oxford: Blackwell Scientific Publications; 1989. pp. 151-207.
109. Li CP, Lee F-Y, Hwang S-J, Lu R-H, Lee WP, Chao Y, et al. Role of substance P in the pathogenesis of spider angiomas in patients with nonalcoholic liver cirrhosis. Am J Gastroenterol 1999; 94:502-507.
110. Li CP, Lee F-Y, Hwang S-J, Lu R-H, Lee W-P, Chao Y, et al. Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor. World J Gastroenterol 2003; 9:2832-2835.
111. Gupta D, Vijaya DR, Gupta R, Dhiman RK, Bhargava M, Verma J, et al. Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepatic portal venous obstruction. Am J Gastroenterol 2001; 96:3395-3399.
112. Fernández-Rodríguez CM, Prieto J, Zozaya JM, Quiroga J, Guitian R. Arteriovenous shunting, hemodynamic changes, and renal sodium retention in liver cirrhosis. Gastroenterology 1993; 104:1139-1145.
113. Colle I, Langlet P, Barriere E, Heller J, Rassiat E, Condat B, et al. Evolution of hypoxemia in patients with severe cirrhosis. J Gastroenterol Hepatol 2002; 17:1106-1109.
114. Freedom RM, Yoo SJ, Perrin D. The biological 'scrabble' of pulmonary arteriovenous malformations: considerations in the setting of cavopulmonary surgery. Cardiol Young 2004; 14:417-437.
115. Lamanna JC, Chavez JC, Pichiule P. Structural and functional adaptation of hypoxia in the rat brain. J Exp Biol 2004; 207:3163-3169.
116. Kanaan A, Parahani R, Douglas RM, Lamanna JC, Haddad GG. Effect of chronic continuous or intermittent hypoxia and re-oxygenation on cerebral capillary density and myelination. Am J Physiol Regul Integr Comp Physiol 2006; 290:R1105-R1114.
117. O'Neill TJ, Wahhoff BR, Owens GK, Skalak TC. Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res 2005; 97:1027-1035.
118. Garin G, Mathews M, Berk BC. Tissue-resident bone marrow-derived progenitor cells. Key players in hypoxia-induced angiogenesis. Circ Res 2005; 97:955-957.
119. Finlayson MH, Superville B. Distribution of cerebral lesions in acquired hepatocerebral degeneration. Brain 1981; 104:79-95.
120. Fogel WA, Andrzejewski W, Maslinski C. Brain histamine in rats with hepatic encephalopathy. J Neurochem 1991; 56:38-43.
121. Lozeva V, MacDonald E, Belcheva A, Hippelainen M, Kosunen H, Tuomisto L. Long-term effects of portocaval anastomosis on the 5-hydroxytryptamine, histamine and catecholamine neurotransmitter systems in rat brain. J Neurochem 1998; 71:1450-1456.
122. Arias J, Menéndez A, López L, Estébanez E, Aller MA, Alsasua A, et al. Morphometric study of the caudate nucleus of rats 3 and 4 months after portacaval shunt. Rev Esp Enf Dig 1985; 67:123-128.
123. Lopez L, González-Pardo H, Cimadevilla JM, Cavas M, Aller MA, et al. Cytochrome oxidase activity of the suprachiasmatic nucleus and pineal gland in rats with portacaval shunt. Exp Neurol 2002; 173:275-282.
124. Lopez L, Cimadevilla JM, Aller MA, Arias J, Nava MP, Arias JL. Diurnal locomotor activity and oxidative metabolism of the suprachiasmatic nucleus in two models of hepatic insufficiency. J Neurol Sci 2003; 212:93-97.
125. Sergeeva OA, Schulz D, Doreulee N, Ponomarenxo AA, Selbach O, Borsch E, et al. Deficits in cortico-striatal synaptic plasticity and behavioral habituation in rats with portacaval anastomosis. Neuroscience 2005; 134:1091-1098.
126. Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003; 302:1760-1765.
127. Pluchino S, Qattrini A, Brambilla E, Gritti A, Salani G, Dina G, et al. Injection of adult neurospheres induces clinical recovery in a chronic model of multiple sclerosis. Nature 2003; 422:688-694.
128. Ben-Hur T, Einstein O, Mizrachi-Kol R, Ben-Menachem O, Reinhartz E, Karussis D, et al. Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis. Glia 2003; 41:73-80.
129. Klassen H, Imfeld KL, Kirov II, Tai L, Gage FH, Yong MJ, et al. Expression of cytokines by multipotent neural progenitor cells. Cytokine 2003; 22:101-106.
130. Bonilla S, Silva A, Valdes L, Geijo E, García-Verdugo JM, Martínez S. Functional neural stem cells derived from adult bone marrow. Neuroscience 2005; 133:85-95.
131. Taupin P. Adult neurogenesis in the mammalian central nervous system: functionality and potential clinical interest. Med Sci Monit 2005; 11:RA247-RA252.
132. Sawamoto KK, Wichterle H, Gonzáles-Pérez O, Cholfin JA, Yamada M, Spassky N, et al. New neurons follow the flow of cerebrospinal fluid in the adult brain. Science 2006; 311:629-632.
133. Hagg T. Molecular regulation of adult CNS neurogenesis: an integrated view. Trends Neurosci 2005; 28:589-595.
134. Zafra F, Lindholm D, Casten E, Martikka J, Thoenen H. Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes. J Neurosci 1992; 12:4793-4799.
135. Zietz B, Lock G, Plach B, Drobnik W, Grossmann J, Scholmerich J, Straub RH. Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis. Eur J Gastroenterol Hepatol 2003; 15:495-501.
136. Krantic S, Mechawar N, Reix S, Quirion R. Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci 2005; 28:670-676.
137. Nouspikel T, Hanawalt PC. Terminally differentiated human neurons repair transcribed genes but display attenuated global DNA repair and modulation of repair gene expression. Mol Cell Biol 2000; 20:1562-1570.
138. Blei AT. Cerebral edema and intracranial hypertension in acute liver failure: distinct aspects of the same problem. Hepatology 1991; 13:376-379.
139. Gazzard BG, Portmann B, Murray-Lyon IM, Williams R. Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med 1975; 44:615-626.
140. Ranjan P, Mishra AM, Kale R, Saraswat VA, Gupta AK. Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: in vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis 2005; 20:181-192.
141. Takahashi H, Koehler RC, Brusilow SW, Traystman RJ. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemia in rats. Am Physiol 1991; 281:H826-H829.
142. Benarroch EE. Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin Proc 2005; 80:1326-1338.
143. Mulligan SJ, Macvicar BA. Calcium transients in astrocyte end feet cause cerebrovascular constrictions. Nature 2004; 431:195-199.
144. Blei AT. The pathophysiology of brain edema in acute liver failure. Neurochem Int 2005; 47:71-75.
145. Jalan R. Pathophysiological basis of therapy of raised intracranial pressure in acute liver failure. Neurochem Int 2005; 47:78-83.
146. Ott P, Clemmesen O, Larsen FS. Cerebral metabolic disturbances in the brain during acute liver failure: from hyperammonemia to energy failure and proteolysis. Neurochem Int 2005; 47:13-18.
147. Takano T, Tian GF, Peng W, Lou N, Libionka W, Han X, Nedergaard M. Astrocyte-mediated control of cerebral blood flow. Nature Neurosci 2005; 9:260-267.
148. Häussinger D, Schliess F. Astrocyte swelling and protein tyrosine nitration in hepatic encephalopathy. Neurochem Int 2005; 47:64-70.
149. Ryter SW, Otterbein LE, Morse D, Choi AM. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 2002; 234-235:249-263.
150. Blei AT. Selection for acute liver failure: have we got it right? Liver Transplant 2005; 11 (Suppl 2):S30-S34.
151. Vaquero J, Blei AT. Mild hypothermia for acute liver failure: a review of mechanisms of action. J Clin Gastroenterol 2005; 4 (Suppl 2):S147-S157.
152. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150.
153. Kloner RA, Jennings RB. Consequences of brief ischemia: stunning preconditioning and their clinical implication. Circulation 2001; 104:3158-3167.
154. Schaller B, Graf R. Hypothermia and stroke: the pathophysiological background. Pathophysiology 2003; 10:7-35.
155. Häussinger D. The role of cellular hydration in the regulation of cell function. Biochem J 1996; 313:697-710.
156. Sen S, Williams R, Jalan R. The pathophysiological basis of acuteon-chronic liver failure. Liver Suppl 2002; 2:5-13.
157. Hindfelt B, Plum F, Duffy TE. Effects of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. J Clin Invest 1977; 59:386-396.
158. Mattson MP. NF-kB in the survival and plasticity of neurons. Neurochem Res 2005; 30:883-893.